At a glance
ClinicalIndex Comparison Record- ✓Diagnosed with persistent asthma for 3 months or longer
- ✓Experienced worsened asthma symptoms during physical activity
- ✓Using an inhaled steroid for the previous 4 weeks or longer (such as Aerobid, Azmacort, Flovent, Pulmicort, QVAR, and Vanceril)
- ✕Used systemic steroids (liquids, pills, or injections) to treat asthma within the previous 3 months
- ✕Have only intermittent, seasonal, or exercise-induced asthma, and not persistent asthma
- ✕Admitted to a hospital within the previous 6 months due to asthma symptoms
- ✕Any poorly controlled medical conditions that may make study participation unsafe or inappropriate (e.g., cystic fibrosis, congenital heart disease, insulin dependent diabetes, glaucoma, drug allergies)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and Adolescent Subjects With Activity-Induced Bronchospasm
In Brief
A Phase 4 clinical trial evaluating Fluticasone propionate/salmeterol and Fluticasone Propionate for Bronchospasm and Activity/Exercise Induced Bronchospasm. Completed, enrolled 248 participants across 50 sites.
Detailed Summary
During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung function tests. All study related medications and medical examinations are provided at no cost. All study drugs are currently available by prescription to patients 4 years and older.
Study Details
Timeline
Interventions
Fluticasone propionate/salmeterol
Fluticasone Propionate